NRX Pharmaceuticals子公司Hope Therapeutics采用Zeta Surgical经FDA批准的Zeta TMS导航系统完成首批患者治疗

美股速递
Jun 25

NRX Pharmaceuticals旗下子公司Hope Therapeutics已成功运用Zeta Surgical公司获得美国食品药品监督管理局(FDA)批准的Zeta TMS导航系统,为首批患者提供了治疗。这一进展标志着该创新技术在临床实践中的初步应用。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10